SCIderm Research Institute

SCIderm is a premier contract research organization (CRO) and site management organization (SMO) specializing exclusively in dermatology, allergology, and aesthetic medicine. Headquartered in Hamburg, Germany, the company provides a full suite of clinical development services, including trial design, project management, regulatory affairs, and medical writing. SCIderm is uniquely positioned through its close integration with the Dermatologikum Hamburg clinic and its dedicated in-house study site, SCIderm Clinics, which facilitate rapid patient recruitment and high-quality data generation for early-to-late phase clinical trials. Since its acquisition by TFS HealthScience in 2016, SCIderm has served as a global center of excellence for dermatology, leveraging its specialized expertise to support major pharmaceutical and biotechnology clients worldwide.